Literature DB >> 7735025

The impact of a brief motivational intervention with opiate users attending a methadone programme.

B Saunders1, C Wilkinson, M Phillips.   

Abstract

During the 1980s Motivational Interviewing emerged as one of the memes of the addictions field. This occurred despite the lack of scientific evidence supporting its utility. In this paper findings of a controlled trial of a brief motivational intervention with illicit drug users (n = 122) attending a methadone clinic are reported. Clients who met the study's inclusion criteria were randomly allocated to either a motivational (experimental, n = 57) or educational (control, n = 65) procedure. Over the 6-month follow-up period the motivational subjects demonstrated a greater, immediate, commitment to abstention, reported more positive expected outcomes for abstention, reported fewer opiate-related problems, were initially more contemplative of change, complied with the methadone programme longer and relapsed less quickly than the control group. There was, however, no difference in terms of the severity of reported opiate dependence and the control group fared better on reported self-efficacy. It was concluded that motivational interventions of the type investigated are useful adjuncts to methadone programmes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735025     DOI: 10.1046/j.1360-0443.1995.90341510.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  37 in total

Review 1.  [Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN].

Authors:  J L Müller; N Saimeh; P Briken; S Eucker; K Hoffmann; M Koller; T Wolf; M Dudeck; C Hartl; A-K Jakovljevic; V Klein; G Knecht; R Müller-Isberner; J Muysers; K Schiltz; D Seifert; A Simon; H Steinböck; W Stuckmann; W Weissbeck; C Wiesemann; R Zeidler
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

2.  An adapted postdonation motivational interview enhances blood donor retention.

Authors:  Kadian S Sinclair; Tavis S Campbell; Patricia M Carey; Eric Langevin; Brent Bowser; Christopher R France
Journal:  Transfusion       Date:  2010-04-23       Impact factor: 3.157

Review 3.  MET meets the real world: design issues and clinical strategies in the Clinical Trials Network.

Authors:  Kathleen M Carroll; Chris Farentinos; Samuel A Ball; Paul Crits-Christoph; Bryce Libby; Jon Morgenstern; Jeanne L Obert; Doug Polcin; George E Woody
Journal:  J Subst Abuse Treat       Date:  2002-09

Review 4.  Recent advances in the psychotherapy of addictive disorders.

Authors:  Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 5.  Motivational interviewing: a systematic review and meta-analysis.

Authors:  Sune Rubak; Annelli Sandbaek; Torsten Lauritzen; Bo Christensen
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

6.  Community program therapist adherence and competence in motivational enhancement therapy.

Authors:  Steve Martino; Samuel A Ball; Charla Nich; Tami L Frankforter; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2008-03-06       Impact factor: 4.492

7.  Facilitating treatment entry among out-of-treatment injection drug users.

Authors:  R E Booth; C Kwiatkowski; M Y Iguchi; F Pinto; D John
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

8.  Motivational tools to improve probationer treatment outcomes.

Authors:  Faye S Taxman; Scott T Walters; Lincoln B Sloas; Jennifer Lerch; Mayra Rodriguez
Journal:  Contemp Clin Trials       Date:  2015-05-22       Impact factor: 2.226

9.  Brief interventions in substance abuse.

Authors:  S Kumar; A Malhotra
Journal:  Indian J Psychiatry       Date:  2000-04       Impact factor: 1.759

Review 10.  Theories and techniques for promoting physical activity behaviours.

Authors:  B H Marcus; T K King; M M Clark; B M Pinto; B C Bock
Journal:  Sports Med       Date:  1996-11       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.